Nanjing Vishee Medical Technology Future Growth
Future criteria checks 5/6
Nanjing Vishee Medical Technology is forecast to grow earnings and revenue by 29.3% and 25.2% per annum respectively. EPS is expected to grow by 29.1% per annum. Return on equity is forecast to be 11.3% in 3 years.
Key information
29.3%
Earnings growth rate
29.1%
EPS growth rate
Medical Equipment earnings growth | 26.5% |
Revenue growth rate | 25.2% |
Future return on equity | 11.3% |
Analyst coverage | Low |
Last updated | 25 Oct 2024 |
Recent future growth updates
Recent updates
Earnings Troubles May Signal Larger Issues for Nanjing Vishee Medical Technology (SHSE:688580) Shareholders
Nov 01Nanjing Vishee Medical Technology Co., Ltd's (SHSE:688580) Shares Leap 35% Yet They're Still Not Telling The Full Story
Oct 07Nanjing Vishee Medical Technology (SHSE:688580) Is Reinvesting At Lower Rates Of Return
Aug 23Investors Don't See Light At End Of Nanjing Vishee Medical Technology Co., Ltd's (SHSE:688580) Tunnel
Jun 06Solid Earnings May Not Tell The Whole Story For Nanjing Vishee Medical Technology (SHSE:688580)
May 02Nanjing Vishee Medical Technology Co., Ltd (SHSE:688580) Shares Fly 30% But Investors Aren't Buying For Growth
Mar 06Nanjing Vishee Medical Technology Co., Ltd Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Feb 29Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 779 | 237 | N/A | 252 | 4 |
12/31/2025 | 624 | 188 | N/A | 202 | 5 |
12/31/2024 | 515 | 151 | N/A | 143 | 5 |
9/30/2024 | 422 | 113 | -2 | 124 | N/A |
6/30/2024 | 434 | 115 | -4 | 125 | N/A |
3/31/2024 | 454 | 128 | -28 | 132 | N/A |
12/31/2023 | 462 | 136 | 1 | 134 | N/A |
9/30/2023 | 437 | 133 | -15 | 143 | N/A |
6/30/2023 | 407 | 126 | -15 | 126 | N/A |
3/31/2023 | 363 | 107 | -2 | 101 | N/A |
12/31/2022 | 322 | 94 | -9 | 86 | N/A |
9/30/2022 | 343 | 132 | 41 | 87 | N/A |
6/30/2022 | 373 | 147 | 50 | 116 | N/A |
3/31/2022 | 404 | 164 | 52 | 147 | N/A |
12/31/2021 | 430 | 178 | 70 | 157 | N/A |
9/30/2021 | 427 | 166 | 70 | 154 | N/A |
6/30/2021 | 413 | 159 | 106 | 153 | N/A |
3/31/2021 | 402 | 158 | 147 | 157 | N/A |
12/31/2020 | 378 | 144 | 109 | 121 | N/A |
9/30/2020 | 349 | 115 | 108 | 123 | N/A |
6/30/2020 | 336 | 111 | 106 | 124 | N/A |
3/31/2020 | 317 | 99 | 79 | 105 | N/A |
12/31/2019 | 319 | 100 | 120 | 141 | N/A |
12/31/2018 | 208 | 63 | 45 | 86 | N/A |
12/31/2017 | 144 | 40 | N/A | 52 | N/A |
6/30/2016 | 89 | 31 | N/A | 22 | N/A |
3/31/2016 | 85 | 29 | N/A | 24 | N/A |
12/31/2015 | 81 | 28 | N/A | 25 | N/A |
12/31/2014 | 58 | 22 | N/A | 15 | N/A |
12/31/2013 | 49 | 14 | N/A | 8 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 688580's forecast earnings growth (29.3% per year) is above the savings rate (2.8%).
Earnings vs Market: 688580's earnings (29.3% per year) are forecast to grow faster than the CN market (26.2% per year).
High Growth Earnings: 688580's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 688580's revenue (25.2% per year) is forecast to grow faster than the CN market (13.8% per year).
High Growth Revenue: 688580's revenue (25.2% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 688580's Return on Equity is forecast to be low in 3 years time (11.3%).